Smoking Rates in Russia Drop to 18.7% in Past 5 Years

Regulations by 2FIRSTS.ai
Jan.22.2024
Smoking Rates in Russia Drop to 18.7% in Past 5 Years
According to the Russian news agency, the smoking rate in Russia has decreased from 24.2% to 18.7% in the past five years.

According to a report by the Russian news agency, data from the Central Medical Organization and the Institute of Information Research of the Russian Ministry of Health reveals that the proportion of smokers in Russia has decreased from 24.2% to 18.7% over the past five years.

 

With the promotion of a healthy lifestyle, the proportion of smokers in Russia has been declining in recent years. According to data from 2022, 19.2% of adults in the country have a smoking habit. The public's understanding of smoking is gradually becoming clear, and measures are being taken to change unhealthy habits. This undoubtedly demonstrates the effectiveness of in-depth collaboration between various levels of government and public institutions in health promotion.

 

A study conducted by the Public Opinion Research Center (VTsIOM) revealed that the smoking rate among adults over 18 is projected to remain at 30% by 2023. The healthcare sector and communities still face significant challenges in reducing smoking and other unhealthy habits.

 

During an interview, lung specialist Alexandra Kochurova revealed that in the past two years, 10-15% of individuals who have been using e-cigarettes, vaporizers, and tobacco heating systems have reported experiencing health issues and have sought medical advice.

 

This phenomenon has attracted significant attention from experts, who have issued a warning that the use of these modern alternatives does not effectively eliminate the health risks associated with smoking.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement
Alan Zhao: What Altria’s on! PLUS Authorization Really Signals About FDA PMTA Enforcement
In this in-depth commentary for 2Firsts, Alan Zhao examines what Altria’s on! PLUS authorization really signals about FDA PMTA enforcement. Beyond the headline approval, FDA’s language, process design and product choices offer rare insight into how nicotine pouch regulation is taking shape—and what it means for industry compliance, in one of the earliest expert reads of the decision.
Regulations
Dec.20 by 2Firsts Perspectives
Philip Morris Korea launches TEREA “Shine Pearl” for IQOS ILUMA, expands capsule range to seven variants
Philip Morris Korea launches TEREA “Shine Pearl” for IQOS ILUMA, expands capsule range to seven variants
Philip Morris Korea said on Feb. 5 it has introduced “TEREA Shine Pearl,” a new TEREA stick designed for the IQOS ILUMA heated-tobacco device. The company said the product delivers a cool sensation and adds a fresh, fruity note when the capsule is crushed, bringing TEREA’s capsule-based lineup in South Korea to seven variants.
Feb.05 by 2FIRSTS.ai
Bangladesh enforces a complete ban on e-cigarettes and emerging tobacco products, with jail and heavy fines
Bangladesh enforces a complete ban on e-cigarettes and emerging tobacco products, with jail and heavy fines
UNB reports that Bangladesh has imposed a complete ban on e-cigarettes, vapes, and other emerging tobacco products as the Smoking and Tobacco Products Use Control (Amendment) Ordinance, 2025 has come into effect.
Jan.04 by 2FIRSTS.ai
MEPs seek Commission answers over EU trade officials’ contacts with PMI
MEPs seek Commission answers over EU trade officials’ contacts with PMI
POLITICO reports that five members of the European Parliament’s health committee want to invite the European Commission to answer questions about its contacts with Philip Morris International (PMI), following a POLITICO and The Examination investigation into extensive meetings between EU trade officials and tobacco lobbyists.
Jan.15 by 2FIRSTS.ai
China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China’s top tobacco regulator has issued a directive aimed at preventing excess capacity and curbing “involution-style” competition in the e-cigarette sector. The notice tightens investment controls, formalizes verified capacity management and requires exporters to submit compliance proof for destination markets, signaling a push toward higher industry concentration and stricter cross-border oversight.
Special Report
Feb.13
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA announced it will convene a Feb. 10, 2026 roundtable with small tobacco product manufacturers to gather feedback on PMTA submissions for ENDS products. The discussion will be viewable online, and a public docket is open for comments through March 12, 2026.
Feb.10 by 2FIRSTS.ai